Avidity
Charles Calderaro III serves as the Chief Technical Officer at Avidity Biosciences, Inc. since January 2025 and previously held the same title at Shoreline Biosciences, Inc. from November 2022 to January 2025. With over three decades in the biotechnology and pharmaceuticals industry, notable positions include Global Head of Technical Operations at Kite Pharma, Senior Vice President Global Manufacturing at BioMarin Pharmaceutical Inc., and Vice President Technical Product Management at Genentech. Calderaro has extensive experience in transforming operations, optimizing technical processes, and managing large teams to deliver innovative products. Educational qualifications include a Bachelor's Degree in Electrical Engineering from the University of Notre Dame, a Master's Degree in Nuclear Engineering from the US Naval Nuclear Power School, and an MBA from Texas Christian University.
This person is not in the org chart
This person is not in any teams
Avidity
2 followers
Avidity Biosciences is pioneering a new class of precision medicines – antibody-siRNA conjugates (ASC™) – to deliver nucleic acid therapeutics against genetic drivers of disease. Our ASCs have drug-like properties similar to antibodies and antibody-drug conjugates. Importantly, their unique siRNA-based “payloads” permit selective targeting of disease-associated mRNAs against virtually any target of interest.